The Skylark Study is a clinical research study evaluating an investigational oral medication in women with severe postpartum depression (PPD)

You may be eligible to participate if you:

• Are between 18 and 45 years old
• Gave birth within the last 12 months
• Have PPD symptoms that began no earlier than the third trimester and no later than the first 4 weeks following delivery
• Frequently feel extremely sad, anxious, or overwhelmed, and these symptoms are associated with severe PPD
• The study doctor will discuss other requirements

If you are eligible and decide to participate, you will receive:

• All study-related procedures and study medication at no cost
• Reasonable compensation may be provided for time and travel